NORTHWEST BIOTHERAPEUTICS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 100.00 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2025-03-31
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-12-31 was 3.33M shares.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-09-30 was 15.00K shares.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-12-31 was 4.25M shares.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-09-30 was 1.75K shares.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 100.00K shares.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 3.40M shares, a 27.92% decline from fiscal 2021.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 4.72M shares, a 11.06% increase from fiscal 2020.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2020 was 4.25M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | 100.00K shares 10-K · filed 2025-03-31 | ||||
| 2022-12-31 | 3.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 3.35M shares derived: sum of 2 quarters · filed 2023-02-28 | 3.40M shares 10-K · filed 2023-02-28 | ||
| 2022-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 69.00K shares 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 54.00K shares 10-Q · filed 2022-08-09 | ||||
| 2021-12-31 | 4.72M shares 10-K · filed 2024-03-05 | ||||
| 2020-12-31 | 4.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 4.25M shares derived: sum of 2 quarters · filed 2023-02-28 | 4.25M shares derived: sum of 3 quarters · filed 2023-02-28 | 4.25M shares 10-K · filed 2023-02-28 | 4.25K shares 10-K · filed 2021-03-31 |
| 2020-09-30 | 1.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-01-15 | 3.00K shares derived: sum of 2 quarters · filed 2021-01-15 | 4.25K shares 10-Q · filed 2021-01-15 | ||
| 2020-06-30 | 1.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 2.50K shares 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | 1.25K shares 10-Q · filed 2020-06-24 | ||||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2020-03-16 | 12.58M shares derived: sum of 3 quarters · filed 2020-03-16 | 12.59M shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | 12.58M shares derived: sum of 2 quarters · filed 2018-11-16 | 12.59M shares 10-Q · filed 2018-11-16 | 12.82M shares derived: sum of 4 quarters · filed 2019-04-02 | |
| 2018-06-30 | 12.58M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 12.59M shares 10-Q · filed 2018-08-14 | 12.82M shares derived: sum of 3 quarters · filed 2019-04-02 | 12.82M shares derived: sum of 4 quarters · filed 2019-04-02 | |
| 2018-03-31 | 11.34K shares 10-Q · filed 2018-05-16 | 249.10K shares derived: sum of 2 quarters · filed 2019-04-02 | 249.10K shares derived: sum of 3 quarters · filed 2019-04-02 | ||
| 2017-12-31 | 237.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | 237.76K shares derived: sum of 2 quarters · filed 2019-04-02 | 238.00K shares 10-K · filed 2019-04-02 | 238.00 shares 10-K · filed 2018-04-17 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | 238.00 shares 10-Q · filed 2017-11-20 | |||
| 2017-06-30 | 238.00 shares 10-Q · filed 2017-08-21 |